Quantification of tumor-associated vasculature as an imaging biomarker for monitoring the response of triple-negative breast cancer to neoadjuvant chemotherapy

被引：0
|
作者：
Wu, Chengyue
Stowers, Casey E.
Xu, Zhan
Lima, Ernesto A. B. F.
Yam, Clinton
Son, Jong Bum
Ma, Jingfei
Rauch, Gaiane M.
Yankeelov, Thomas E.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5569
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Response to Neoadjuvant Chemotherapy and Survival in Japanese Patients with Triple-Negative Breast Cancer.
    Ohtani, S.
    Kochi, M.
    Ito, M.
    Takada, S.
    Matsuura, H.
    Higaki, K.
    CANCER RESEARCH, 2011, 71
  • [32] Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
    Zhang, Wei
    Li, Emma
    Wang, Lily
    Lehmann, Brian D. D.
    Chen, X. Steven
    CANCERS, 2023, 15 (08)
  • [33] Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
    van den Ende, Nadine S. S.
    Nguyen, Anh H. H.
    Jager, Agnes
    Kok, Marleen
    Debets, Reno
    van Deurzen, Carolien H. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [34] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [35] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Jiannan Wu
    Shunrong Li
    Weijuan Jia
    Fengxi Su
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1505 - 1510
  • [36] The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial-Mesenchymal Transition
    Zapperi, Stefano
    La Porta, Caterina A. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [37] SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer
    Xu, Lu
    Che, Xiaofang
    Wu, Ying
    Song, Na
    Shi, Sha
    Wang, Shuo
    Li, Ce
    Zhang, Lingyun
    Zhang, Xinlian
    Qu, Xiujuan
    Teng, Yuee
    ONCOLOGY REPORTS, 2018, 39 (05) : 2315 - 2323
  • [38] Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy
    Liu, Yan
    Zhang, Dan
    Zhang, Zongquan
    Liang, Xiaoya
    Yang, Xi
    Ding, Nianhui
    Nie, Yu
    Li, Chunhong
    Journal of Colloid and Interface Science, 2024, 657 : 598 - 610
  • [39] Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy
    Aldrich, Jeffrey
    Canning, Madison
    Bhave, Manali
    CLINICAL BREAST CANCER, 2023, 23 (08) : 832 - 834
  • [40] Multifunctional nanoparticles inhibit tumor and tumor-associated macrophages for triple-negative breast cancer therapy
    Liu, Yan
    Zhang, Dan
    Zhang, Zongquan
    Liang, Xiaoya
    Yang, Xi
    Ding, Nianhui
    Nie, Yu
    Li, Chunhong
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2024, 657 : 598 - 610
12345